Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Annovis Bio, Inc. (ANVS) Debt to Capital Ratio data is not available for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-9.83M |
|
-- |
|
-- |
|
$9.71M |
|
$-9.71M |
|
$-0.13M |
|
$-9.83M |
|
$-9.83M |
|
$-9.83M |
|
$-9.83M |
|
$-9.83M |
|
$-9.83M |
|
$-9.71M |
|
$-9.71M |
|
20.55M |
|
20.55M |
|
$-0.39 |
|
$-0.39 |
|
| Balance Sheet Financials | |
$21.08M |
|
-- |
|
-- |
|
$21.08M |
|
$3.64M |
|
-- |
|
$0.59M |
|
$4.23M |
|
$16.85M |
|
$16.85M |
|
$16.85M |
|
27.20M |
|
| Cash Flow Statement Financials | |
$-25.62M |
|
-- |
|
$34.60M |
|
$10.55M |
|
$19.53M |
|
$8.98M |
|
$1.80M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.80 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-25.62M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-58.36% |
|
-58.36% |
|
-46.65% |
|
-58.36% |
|
$0.62 |
|
$-1.25 |
|
$-1.25 |
|